Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Kogan AE"'
Autor:
Ivan A Katrukha, Alexey V. Kharitonov, Kogan Ae, Anastasia V. Bereznikova, Ekaterina V. Koshkina, Alexey G. Katrukha, Alexandra V Vylegzhanina, Vladimir L. Filatov, Natalia N. Tamm
Publikováno v:
Clinical Chemistry. 64:1104-1112
BACKGROUNDIn the blood of patients with acute myocardial infarction (AMI), cardiac troponin I (cTnI) presents as an intact molecule with a repertoire of proteolytic fragments. The degradation of cTnI might negatively influence its precise immunodetec
Autor:
Ekaterina V. Koshkina, Alexey G. Katrukha, Kogan Ae, Marina V. Serebryakova, Ivan A Katrukha, Anastasia V. Bereznikova, Alexandra V Vylegzhanina
Publikováno v:
Clinical Chemistry. 63:1094-1100
BACKGROUNDCardiac troponin T (cTnT) is an acknowledged biomarker of acute myocardial infarction (AMI) that is known to be prone to proteolytic degradation in serum. Such degradation is usually explained by the action of μ-calpain, although there cou
Autor:
A.N. Kara, Ekaterina V. Koshkina, Kogan Ae, Alexey G. Katrukha, Anastasia V. Bereznikova, Olga V Antipova, Alexandra V Vylegzhanina, Ivan A Katrukha
Publikováno v:
Clinical Chemistry. 63:343-350
BACKGROUND Autoantibodies to cardiac troponins (TnAAbs) could negatively affect cardiac troponin I (cTnI) measurements by TnAAbs-sensitive immunoassays. We investigated the epitope specificity of TnAAbs and its influence on cTnI immunodetection in pa
Autor:
Alexey G. Katrukha, Kogan Ae, Marina N. Bloshchitsyna, Alexandra V Vylegzhanina, Anastasia V. Bereznikova, Vladimir L. Filatov, Ivan A Katrukha, Ekaterina V. Koshkina, Agnessa P Bogomolova
Publikováno v:
Clinical chemistry. 65(7)
BACKGROUNDThe measurement of cardiac isoforms of troponin I (cTnI) and troponin T (cTnT) is widely used for the diagnosis of acute myocardial infarction (AMI). However, there are conflicting data regarding what forms of cTnI and cTnT are present in t
Autor:
Anastasiya V. Bereznikova, Ivan A Katrukha, Alexandra V Vylegzhanina, Kogan Ae, Alexey G. Katrukha, A. Bogomolova, Ekaterina V. Koshkina
Publikováno v:
Clinica Chimica Acta. 493:S196-S197
Autor:
Alexey G. Katrukha, Anastasia V. Bereznikova, Kogan Ae, Kadriya S. Mukharyamova, Vladimir L. Filatov, Marina N. Bloshchitsyna, Ekaterina V. Koshkina
Publikováno v:
Blood Coagulation & Fibrinolysis
Fibrin degradation results in the formation of fibrin degradation products (FDPs) of different molecular weights, which include D-dimer. Commercial D-dimer assays recognize multiple forms of FDP with different specificity. As a result, the absence of
Publikováno v:
International Journal of Laboratory Hematology. 29:335-340
Transferrin receptor is a transmembrane protein that mediates iron transport from blood into cells. The extracellular part of this receptor circulates in blood as soluble transferrin receptor (sTfR) and the immunological determination of this paramet
Publikováno v:
Thrombosis Research. 101:299-310
Activated partial thromboplastin time (APTT) is a laboratory test for the diagnosis of blood coagulation disorders. The test consists of two stages: The first one is the preincubation of a plasma sample with negatively charged materials (kaolin, ella
Publikováno v:
Thrombosis Research. 89:227-232
A mathematical model for the prothrombin time test is proposed. The time course of clotting factor activation during coagulation was calculated, and the sensitivity of the test to a decrease in the concentrations of coagulation proteins or their acti
Publikováno v:
Thrombosis Research. 85:267-272